Evolution of the Average Target: Tenax Therapeutics, Inc.

Evolution of the Average Target - Tenax Therapeutics, Inc.

Evolution of the Target Price: Tenax Therapeutics, Inc.

Evolution of the Target Price - Tenax Therapeutics, Inc.

Changes in Analyst Recommendations: Tenax Therapeutics, Inc.

d0bd5.JFs1eyXnLlOz3YvKMC2R_ZOC2eXEnAtd6RwiK9QkD0o.HBhcFUCtYSfHs9KfZGPoh97Bm4eK5ntlmncURqNiUARtFmAVaaV2Yd-L2g~94656a63fa2be3a36f19fdf69400301a

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+459.59%
+32.59%
+28.09%
+10.26%
+8.34%
+15.58%
+38.43%
+38.53%
+4.99%
+31.23%
Average +66.76%
Weighted average by Cap. +23.46%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
1.720USD
Average target price
9.625USD
Spread / Average Target
+459.59%
High Price Target
35.00USD
Spread / Highest target
+1,934.88%
Low Price Target
4.000USD
Spread / Lowest Target
+132.56%

Analyst Consensus Detail

Analyst consensus - Tenax Therapeutics, Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Tenax Therapeutics, Inc.
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Tenax Therapeutics, Inc.
  1. Stock Market
  2. Stocks
  3. TENX Stock
  4. Consensus Tenax Therapeutics, Inc.